| MLEC | Moolec Science SA | 0.01 | -100.00% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.99% |
| ENVB | Enveric Biosciences Inc | 0.08 | -99.98% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -99.97% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -99.96% |
| JAGX | Jaguar Health Inc | 0.30 | -99.91% |
| LITS | Lite Strategy Inc | 0.31 | -99.91% |
| AFMD | Affimed N.V. | 0.53 | -99.85% |
| HRTX | Heron Therapeutics Inc | 0.54 | -99.85% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -99.84% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -99.83% |
| FTRE | Fortrea Holdings Inc | 0.63 | -99.82% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -99.82% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -99.79% |
| CELU | Celularity Inc - Class A | 0.85 | -99.76% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -99.75% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -99.72% |
| GOSS | Gossamer Bio Inc | 0.98 | -99.72% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -99.68% |
| XLO | Xilio Therapeutics Inc | 1.14 | -99.68% |
| PTN | Palatin Technologies Inc | 1.22 | -99.65% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -99.65% |
| FBIOP | Fortress Biotech Inc | 1.25 | -99.64% |
| HCWB | HCW Biologics Inc | 1.25 | -99.64% |
| CRIS | Curis Inc | 1.30 | -99.63% |
| IMRN | Immuron Ltd | 1.34 | -99.62% |
| CSBR | Champions Oncology Inc | 1.36 | -99.61% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -99.60% |
| RVNC | Revance Therapeutics Inc | 1.48 | -99.58% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -99.57% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -99.56% |
| MDXG | Mimedx Group Inc | 1.61 | -99.54% |
| SPRO | Spero Therapeutics Inc | 1.61 | -99.54% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -99.54% |
| CRMD | CorMedix Inc | 1.62 | -99.54% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -99.51% |
| AGEN | Agenus Inc | 1.71 | -99.51% |
| MGNX | Macrogenics Inc | 1.74 | -99.51% |
| GLPG | Galapagos NV | 1.74 | -99.50% |
| SVA | Sinovac Biotech Ltd | 1.83 | -99.48% |
| PBYI | Puma Biotechnology Inc | 1.85 | -99.47% |
| NERV | Minerva Neurosciences Inc | 1.87 | -99.47% |
| FBIO | Fortress Biotech Inc | 1.87 | -99.47% |
| THTX | Theratechnologies Inc | 1.98 | -99.43% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -99.40% |
| NAGE | Niagen Bioscience Inc | 2.12 | -99.40% |
| XBIO | Xenetic Biosciences Inc | 2.15 | -99.39% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -99.37% |
| MGX | Metagenomi Inc | 2.23 | -99.37% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | -99.36% |
| NVAX | Novavax Inc | 2.32 | -99.34% |
| SPRC | SciSparc Ltd | 2.33 | -99.34% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -99.31% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | -99.31% |
| HYFT | MindWalk Holdings Corp | 2.48 | -99.29% |
| CDXS | Codexis Inc | 2.48 | -99.29% |
| SAVA | Cassava Sciences Inc. | 2.54 | -99.28% |
| RIGL | Rigel Pharmaceuticals | 2.54 | -99.28% |
| PHAR | Pharming Group N.V. | 2.55 | -99.27% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | -99.26% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -99.24% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -99.23% |
| REVB | Revelation Biosciences Inc | 2.88 | -99.18% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -99.16% |
| ARDX | Ardelyx Inc | 2.98 | -99.15% |
| CGEN | Compugen Ltd | 2.99 | -99.15% |
| VERU | Veru Inc | 3.11 | -99.11% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | -99.11% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | -99.11% |
| EVGN | Evogene Ltd | 3.17 | -99.10% |
| ICCC | Immucell Corp | 3.24 | -99.08% |
| BGMS | Bio Green Med Solution Inc | 3.28 | -99.07% |
| AAPG | Ascentage Pharma Group International | 3.28 | -99.06% |
| MNKD | Mannkind Corp | 3.32 | -99.05% |
| VALN | Valneva SE | 3.35 | -99.05% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | -99.04% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | -99.04% |
| EVAX | Evaxion Biotech A/S | 3.38 | -99.04% |
| PTHS | Channel Therapeutics Corporation | 3.41 | -99.03% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | -99.00% |
| BCAB | BioAtla Inc | 3.54 | -98.99% |
| SLDB | Solid Biosciences Inc | 3.65 | -98.96% |
| CUE | Cue Biopharma Inc | 3.66 | -98.96% |
| IPSC | Century Therapeutics Inc | 3.72 | -98.94% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -98.92% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | -98.91% |
| INVA | Innoviva Inc | 3.81 | -98.91% |
| CLLS | Cellectis | 3.85 | -98.90% |
| LEGN | Legend Biotech Corp | 3.91 | -98.88% |
| ONCO | Onconetix Inc | 3.92 | -98.88% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | -98.86% |
| ADMA | Adma Biologics Inc | 4.03 | -98.85% |
| IMCR | Immunocore Holdings plc | 4.27 | -98.78% |
| INCY | Incyte Corp | 4.28 | -98.78% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | -98.77% |
| IVVD | Invivyd Inc | 4.31 | -98.77% |
| STRO | Sutro Biopharma Inc | 4.33 | -98.77% |
| GERN | Geron Corp | 4.51 | -98.71% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -98.70% |
| GMAB | Genmab | 4.58 | -98.69% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | -98.68% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | -98.66% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | -98.66% |
| ABUS | Arbutus Biopharma Corp | 4.76 | -98.64% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | -98.64% |
| APLM | Apollomics Inc - Class A | 4.77 | -98.64% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | -98.64% |
| CHRS | Coherus Biosciences Inc | 4.77 | -98.64% |
| TRAW | Traws Pharma Inc | 4.77 | -98.64% |
| QTTB | Q32 Bio Inc | 4.95 | -98.59% |
| ZLAB | Zai Lab Ltd | 4.96 | -98.58% |
| DTIL | Precision Biosciences Inc | 5.04 | -98.56% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -98.55% |
| VYGR | Voyager Therapeutics Inc | 5.23 | -98.51% |
| ELAB | PMGC Holdings Inc | 5.26 | -98.50% |
| PSTV | Plus Therapeutics Inc | 5.42 | -98.45% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | -98.45% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | -98.43% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | -98.40% |
| ONC | BeiGene Ltd | 5.63 | -98.39% |
| RNA | Atrium Therapeutics Inc | 5.70 | -98.37% |
| EXEL | Exelixis Inc | 5.89 | -98.32% |
| HALO | Halozyme Therapeutics Inc | 5.90 | -98.32% |
| ARVN | Arvinas Inc | 5.98 | -98.29% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -98.28% |
| GYRE | Gyre Therapeutics Inc | 6.04 | -98.28% |
| SCPH | scPharmaceuticals Inc | 6.10 | -98.26% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | -98.25% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | -98.22% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | -98.16% |
| KROS | Keros Therapeutics Inc | 6.58 | -98.12% |
| MRKR | Marker Therapeutics Inc | 6.63 | -98.11% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | -98.10% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | -98.04% |
| ANAB | AnaptysBio Inc | 6.90 | -98.03% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | -98.03% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | -97.97% |
| TCRX | Tscan Therapeutics Inc | 7.14 | -97.97% |
| RGNX | Regenxbio Inc | 7.23 | -97.94% |
| LENZ | LENZ Therapeutics Inc | 7.45 | -97.88% |
| ASMB | Assembly Biosciences Inc | 7.46 | -97.87% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | -97.84% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | -97.84% |
| ALGS | Aligos Therapeutics Inc | 7.59 | -97.84% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | -97.83% |
| PRTA | Prothena Corporation plc | 7.62 | -97.83% |
| NTBL | Notable Labs Inc Ord | 7.65 | -97.82% |
| SEER | Seer Inc - Class A | 7.83 | -97.77% |
| PTCT | PTC Therapeutics Inc | 7.83 | -97.77% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | -97.73% |
| TBPH | Theravance Biopharma Inc | 7.99 | -97.72% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | -97.70% |
| VCEL | Vericel Corp | 8.06 | -97.70% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | -97.69% |
| IMMP | Immutep Ltd | 8.12 | -97.68% |
| BNTX | BioNTech SE | 8.29 | -97.64% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | -97.62% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | -97.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | -97.50% |
| ALEC | Alector Inc | 9.04 | -97.42% |
| GOVX | Geovax Labs Inc | 9.09 | -97.41% |
| TECH | Bio-Techne Corp | 9.17 | -97.39% |
| LPCN | Lipocine Inc | 9.51 | -97.29% |
| NXTC | Nextcure Inc | 9.52 | -97.29% |
| BLRX | Bioline Rx Ltd | 9.56 | -97.27% |
| ACET | Adicet Bio Inc | 9.72 | -97.23% |
| SNGX | Soligenix Inc | 9.78 | -97.21% |
| TVTX | Travere Therapeutics Inc | 9.84 | -97.19% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | -97.19% |
| VSTM | Verastem Inc | 9.87 | -97.19% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | -97.18% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | -97.14% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | -97.09% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | -97.04% |
| OABI | OmniAb Inc | 10.42 | -97.03% |
| PYXS | Pyxis Oncology Inc | 10.69 | -96.95% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | -96.88% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | -96.82% |
| ARGX | Argen X SE | 11.27 | -96.79% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | -96.77% |
| XNCR | Xencor Inc | 11.41 | -96.75% |
| DYAI | Dyadic International Inc DE | 11.58 | -96.70% |
| PALI | Palisade Bio Inc | 11.78 | -96.64% |
| CCCC | C4 Therapeutics Inc | 11.93 | -96.60% |
| TGTX | TG Therapeutics Inc | 12.00 | -96.58% |
| MRNA | Moderna Inc | 12.18 | -96.53% |
| XBIT | XBiotech Inc | 12.23 | -96.51% |
| CORT | Corcept Therapeutics Inc | 12.63 | -96.40% |
| MDWD | MediWound Ltd | 12.65 | -96.39% |
| ICU | SeaStar Medical Holding Corp | 12.86 | -96.33% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | -96.31% |
| SRRK | Scholar Rock Holding Corp | 13.14 | -96.25% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | -96.25% |
| URGN | UroGen Pharma Ltd | 13.37 | -96.19% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | -96.15% |
| ANL | Adlai Nortye Ltd | 13.52 | -96.14% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | -96.12% |
| XCUR | Exicure Inc | 13.61 | -96.12% |
| CRVO | CervoMed Inc | 13.61 | -96.12% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | -96.10% |
| EDIT | Editas Medicine Inc | 13.68 | -96.10% |
| KURA | Kura Oncology Inc | 13.93 | -96.03% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | -96.00% |
| COYA | Coya Therapeutics Inc | 14.30 | -95.92% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | -95.91% |
| MGTX | MeiraGTx Holdings plc | 14.58 | -95.84% |
| XOMA | XOMA Royalty Corp | 14.63 | -95.83% |
| CVAC | CureVac N.V. | 14.83 | -95.77% |
| APLT | Applied Therapeutics Inc | 14.86 | -95.76% |
| RCUS | Arcus Biosciences Inc | 14.93 | -95.74% |
| CRBU | Caribou Biosciences Inc | 15.32 | -95.63% |
| IDYA | Ideaya Biosciences Inc | 15.70 | -95.52% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | -95.36% |
| WVE | Wave Life Sciences Ltd | 16.43 | -95.32% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | -95.30% |
| LGVN | Longeveron Inc - Class A | 16.51 | -95.29% |
| ACOG | Alpha Cognition Inc | 16.80 | -95.21% |
| AXSM | Axsome Therapeutics Inc | 17.09 | -95.13% |
| PLUR | Pluri Inc | 17.50 | -95.01% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | -94.99% |
| BEAM | Beam Therapeutics Inc | 17.79 | -94.93% |
| PRQR | ProQR Therapeutics N.V | 17.90 | -94.90% |
| IMNN | Imunon Inc | 17.94 | -94.88% |
| IPHA | Innate Pharma | 18.77 | -94.65% |
| ASND | Ascendis Pharma A/S | 20.12 | -94.26% |
| NRXS | Neuraxis Inc | 20.19 | -94.24% |
| EQ | Equillium Inc | 20.22 | -94.23% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | -94.13% |
| VIVS | VivoSim Labs Inc | 20.99 | -94.02% |
| NTRB | Nutriband Inc | 21.11 | -93.98% |
| SEPN | Septerna Inc | 21.25 | -93.94% |
| PRLD | Prelude Therapeutics Inc | 21.25 | -93.94% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | -93.73% |
| ZYME | Zymeworks BC Inc | 22.33 | -93.63% |
| CTMX | CytomX Therapeutics Inc | 22.42 | -93.61% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | -93.34% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | -93.23% |
| KALA | Kala Bio Inc | 23.75 | -93.23% |
| IRD | Ocuphire Pharma Inc | 23.98 | -93.16% |
| IGC | IGC Pharma Inc | 24.19 | -93.10% |
| VIR | Vir Biotechnology Inc | 24.75 | -92.94% |
| BRTX | BioRestorative Therapies Inc | 24.97 | -92.88% |
| NBP | NovaBridge Biosciences. | 25.39 | -92.76% |
| KRYS | Krystal Biotech Inc | 25.84 | -92.63% |
| CGEM | Cullinan Oncology Inc | 25.86 | -92.63% |
| ABCL | AbCellera Biologics Inc | 25.99 | -92.59% |
| RNXT | RenovoRx Inc | 26.04 | -92.58% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | -92.46% |
| DARE | Dare Bioscience Inc | 26.79 | -92.36% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | -92.33% |
| ABVC | ABVC BioPharma Inc | 27.42 | -92.18% |
| ABEO | Abeona Therapeutics Inc | 27.67 | -92.11% |
| BBIO | BridgeBio Pharma Inc | 27.92 | -92.04% |
| NTLA | Intellia Therapeutics Inc | 28.12 | -91.98% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | -91.97% |
| INSM | Insmed Inc | 28.42 | -91.90% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | -91.63% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | -91.43% |
| ADAG | Adagene Inc | 31.61 | -90.99% |
| MESO | Mesoblast Ltd | 33.10 | -90.56% |
| SRZN | Surrozen Inc | 33.76 | -90.37% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | -90.19% |
| IMTX | Immatics N.V | 34.70 | -90.11% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | -90.07% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | -89.75% |
| CBIO | N/A | 36.36 | -89.63% |
| TOVX | Theriva Biologics Inc | 37.16 | -89.40% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | -88.79% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | -88.36% |
| OCUL | Ocular Therapeutix Inc | 40.81 | -88.36% |
| NKTR | Nektar Therapeutics | 41.48 | -88.17% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | -87.98% |
| HYPD | Eyenovia Inc | 43.89 | -87.49% |
| EVMN | Evommune Inc | 44.84 | -87.21% |
| MCRB | Seres Therapeutics Inc | 45.04 | -87.16% |
| BYSI | BeyondSpring Inc | 45.99 | -86.89% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | -86.87% |
| TRDA | Entrada Therapeutics Inc | 47.22 | -86.54% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | -86.31% |
| KRRO | Korro Bio Inc | 48.91 | -86.05% |
| SPRB | Spruce Biosciences Inc | 49.19 | -85.97% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | -85.51% |
| PPBT | Purple Biotech Ltd | 51.90 | -85.20% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | -85.03% |
| ALLR | Allarity Therapeutics Inc | 53.04 | -84.88% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | -84.76% |
| FATE | Fate Therapeutics Inc | 55.18 | -84.27% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | -84.16% |
| VYNE | VYNE Therapeutics Inc | 55.68 | -84.12% |
| PGEN | Precigen Inc | 57.77 | -83.53% |
| IBRX | ImmunityBio Inc | 57.87 | -83.50% |
| STOK | Stoke Therapeutics Inc | 58.07 | -83.44% |
| COCP | Cocrystal Pharma Inc | 58.22 | -83.40% |
| ONCY | Oncolytics Biotech Inc | 58.60 | -83.29% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | -82.94% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | -82.50% |
| NBTX | Nanobiotix | 62.26 | -82.25% |
| OVID | Ovid Therapeutics Inc | 64.47 | -81.62% |
| ACIU | AC Immune SA | 65.70 | -81.27% |
| EPIX | Essa Pharma Inc | 65.79 | -81.24% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | -80.99% |
| NRIX | Nurix Therapeutics Inc | 67.32 | -80.81% |
| JANX | Janux Therapeutics Inc | 71.18 | -79.70% |
| ADXN | Addex Therapeutics Ltd | 71.50 | -79.61% |
| APRE | Aprea Therapeutics Inc | 73.15 | -79.14% |
| IVA | Inventiva | 73.66 | -79.00% |
| LEXX | Lexaria Bioscience Corp | 75.14 | -78.58% |
| SILO | SILO Pharma Inc | 76.31 | -78.24% |
| OMER | Omeros Corporation | 76.82 | -78.10% |
| MAZE | Maze Therapeutics Inc | 81.33 | -76.81% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | -76.26% |
| IMA | Ikena Oncology Inc | 83.32 | -76.24% |
| TNGX | Tango Therapeutics Inc | 86.42 | -75.36% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | -75.32% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | -74.73% |
| OGEN | Oragenics Inc | 89.28 | -74.54% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | -74.49% |
| HUMA | Humacyte Inc | 90.61 | -74.16% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | -73.81% |
| CVM | Cel-Sci Corp | 92.88 | -73.52% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | -73.09% |
| RAPP | Rapport Therapeutics Inc | 95.49 | -72.77% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | -72.30% |
| HIND | ReShape Lifesciences Inc | 104.32 | -70.26% |
| MREO | Mereo Biopharma Group Plc | 104.68 | -70.15% |
| CYTK | Cytokinetics Inc | 105.12 | -70.03% |
| OCGN | Ocugen Inc | 108.42 | -69.09% |
| RLYB | Rallybio Corp | 109.04 | -68.91% |
| AIM | AIM ImmunoTech Inc. | 112.05 | -68.05% |
| MNOV | Medicinova Inc | 113.02 | -67.77% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | -67.50% |
| SKYE | Skye Bioscience Inc | 117.90 | -66.38% |
| UPB | Upstream Bio Inc | 119.09 | -66.04% |
| GRDX | Entero Therapeutics Inc | 119.29 | -65.99% |
| ZBIO | Zenas Biopharma Inc | 119.50 | -65.93% |
| CAPR | Capricor Therapeutics Inc | 124.43 | -64.52% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | -59.32% |
| OPT | Opthea Ltd | 151.40 | -56.83% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | -56.52% |
| DBVT | DBV Technologies | 153.33 | -56.28% |
| PRME | Prime Medicine Inc | 156.26 | -55.45% |
| MOLN | Molecular Partners AG | 156.56 | -55.36% |
| QURE | uniQure N.V. | 157.78 | -55.01% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | -52.76% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | -51.56% |
| CRDF | Cardiff Oncology Inc | 175.81 | -49.87% |
| KYMR | Kymera Therapeutics Inc | 182.36 | -48.00% |
| GRCE | Acasti Pharma Inc | 197.75 | -43.62% |
| LSTA | Lisata Therapeutics Inc | 200.88 | -42.72% |
| GTBP | GT Biopharma Inc | 204.96 | -41.56% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | -39.32% |
| SER | AgeX Therapeutics Inc | 224.96 | -35.86% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | -35.45% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | -32.11% |
| AZTR | Azitra Inc | 239.97 | -31.58% |
| GANX | Gain Therapeutics Inc | 255.50 | -27.15% |
| CMPX | Compass Therapeutics Inc | 269.28 | -23.22% |
| ATYR | Atyr Pharma Inc | 275.73 | -21.38% |
| CYBN | Cybin Inc | 278.25 | -20.66% |
| IBIO | iBio Inc | 279.86 | -20.20% |
| YDES | YD Bio Ltd | 315.05 | -10.17% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | -8.82% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | -8.56% |
| CLRB | Cellectar Biosciences Inc | 348.47 | -0.64% |
| AUTL | Autolus Therapeutics plc | 372.63 | +6.25% |
| ANIX | Anixa Biosciences Inc | 377.78 | +7.72% |
| RLAY | Relay Therapeutics Inc | 398.28 | +13.56% |
| TENX | Tenax Therapeutics Inc | 414.72 | +18.25% |
| CADL | Candel Therapeutics Inc | 436.42 | +24.44% |
| ALMS | Alumis Inc | 437.16 | +24.65% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +36.37% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +40.13% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +53.62% |
| TVRD | Cara Therapeutics Inc | 559.61 | +59.56% |
| IMRX | Immuneering Corp Class A | 563.62 | +60.70% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +61.31% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +66.40% |
| SLN | Silence Therapeutics Plc | 588.32 | +67.75% |
| STTK | Shattuck Labs Inc | 608.39 | +73.47% |
| LNAI | Lunai Bioworks Inc | 645.16 | +83.95% |
| IMNM | Immunome Inc | 646.50 | +84.34% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +85.40% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +87.23% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +98.39% |
| OCS | Oculis Holding AG | 705.51 | +101.16% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +107.41% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +108.77% |
| INMB | INmune Bio Inc | 760.34 | +116.79% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +131.87% |
| SNTI | Senti Biosciences Inc | 852.38 | +143.04% |
| COGT | Cogent Biosciences Inc | 861.15 | +145.54% |
| PROK | ProKidney Corp - Class A | 876.39 | +149.88% |
| ABSI | Absci Corp | 900.52 | +156.76% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +171.77% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +193.53% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +240.80% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +245.34% |
| IBO | Impact BioMedical Inc | 1260.68 | +259.46% |
| CGON | Cg Oncology Inc | 1269.73 | +262.04% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +263.64% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +276.39% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +316.02% |
| ENTX | Entera Bio Ltd | 1547.08 | +341.12% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +381.62% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +388.25% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +433.78% |
| MBIO | Mustang Bio Inc | 2205.73 | +528.92% |
| ABVX | Abivax | 2425.97 | +591.71% |
| PULM | Pulmatrix Inc | 2459.21 | +601.19% |
| BCDA | BioCardia Inc | 2520.59 | +618.69% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +689.84% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +757.70% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +775.86% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +891.20% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +891.57% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +901.75% |
| CMRX | Chimerix Inc | 3613.35 | +930.27% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +938.91% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +1009.52% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +1045.14% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +1065.63% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +1350.15% |
| IFRX | InflaRx N.V. | 6161.81 | +1656.91% |
| GUTS | Fractyl Health Inc | 7575.74 | +2060.06% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +2119.54% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +2316.71% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +2466.70% |
| RVMD | Revolution Medicines Inc | 9035.10 | +2476.16% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +2715.71% |
| ALT | Altimmune Inc | 10694.01 | +2949.17% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +3113.97% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +3579.41% |
| GNLX | Genelux Corp | 16310.70 | +4550.64% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +5016.55% |
| DSGN | Design Therapeutics Inc | 29402.82 | +8283.58% |
| TRML | Tourmaline Bio Inc | 30893.12 | +8708.51% |
| TIL | Instil Bio Inc | 54248.82 | +15367.88% |
| ETNB | 89bio Inc | 111568.68 | +31711.41% |
| EDSA | Edesa Biotech Inc | 130462.29 | +37098.51% |
| SVRA | Savara Inc | 145272.62 | +41321.36% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +136296.48% |
| NKTX | Nkarta Inc | 1.00M | +285028.47% |